1. Home
  2. LPA vs ESPR Comparison

LPA vs ESPR Comparison

Compare LPA & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • ESPR
  • Stock Information
  • Founded
  • LPA 2013
  • ESPR 2008
  • Country
  • LPA United States
  • ESPR United States
  • Employees
  • LPA N/A
  • ESPR N/A
  • Industry
  • LPA
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPA
  • ESPR Health Care
  • Exchange
  • LPA Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • LPA 211.9M
  • ESPR 305.0M
  • IPO Year
  • LPA N/A
  • ESPR 2013
  • Fundamental
  • Price
  • LPA $6.16
  • ESPR $0.89
  • Analyst Decision
  • LPA
  • ESPR Buy
  • Analyst Count
  • LPA 0
  • ESPR 7
  • Target Price
  • LPA N/A
  • ESPR $5.93
  • AVG Volume (30 Days)
  • LPA 22.6K
  • ESPR 5.7M
  • Earning Date
  • LPA 05-14-2025
  • ESPR 05-06-2025
  • Dividend Yield
  • LPA N/A
  • ESPR N/A
  • EPS Growth
  • LPA N/A
  • ESPR N/A
  • EPS
  • LPA N/A
  • ESPR N/A
  • Revenue
  • LPA $43,862,372.00
  • ESPR $259,574,000.00
  • Revenue This Year
  • LPA N/A
  • ESPR $5.70
  • Revenue Next Year
  • LPA N/A
  • ESPR N/A
  • P/E Ratio
  • LPA N/A
  • ESPR N/A
  • Revenue Growth
  • LPA 11.22
  • ESPR 12.99
  • 52 Week Low
  • LPA $6.00
  • ESPR $0.82
  • 52 Week High
  • LPA $525.00
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • LPA N/A
  • ESPR 36.95
  • Support Level
  • LPA N/A
  • ESPR $0.93
  • Resistance Level
  • LPA N/A
  • ESPR $1.11
  • Average True Range (ATR)
  • LPA 0.00
  • ESPR 0.10
  • MACD
  • LPA 0.00
  • ESPR 0.02
  • Stochastic Oscillator
  • LPA 0.00
  • ESPR 25.10

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: